The few studies that incorporated APOE genotyping in clinically aggressive models of PCa (PC3 and DU145 cells) and hormone-resistant PCa patients suggested that the APOE ε2/ε4 genotypes contributed to a more advanced disease [137,138] and similarly exhibited higher cellular cholesterol retention [137,139]. The gene discussed is APOE; the disease is posterior cortical atrophy.